T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| 1 |
Broadcom
AVGO
|
$898M |
| 2 |
Danaher
DHR
|
$756M |
| 3 |
Intuit
INTU
|
$719M |
| 4 |
PTC
PTC
|
$567M |
| 5 |
Salesforce
CRM
|
$412M |
Top Sells
| 1 |
CrowdStrike
CRWD
|
$882M |
| 2 |
Spotify
SPOT
|
$761M |
| 3 |
KKR & Co
KKR
|
$607M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$556M |
| 5 |
Goldman Sachs
GS
|
$547M |
Sector Composition
| 1 | Technology | 24.77% |
| 2 | Healthcare | 20.33% |
| 3 | Industrials | 12.32% |
| 4 | Consumer Discretionary | 11.57% |
| 5 | Financials | 10.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BFS
376
Saul Centers
BFS
$812M
| $54.1M | 0.03% |
1,472,376
-357,812
| -20% | -$13.2M |
|
377
Kilroy Realty
KRC
$5.05B
| $53.9M | 0.03% |
1,729,984
+82,322
| +5% | +$2.57M |
|
378
LCI Industries
LCII
$2.57B
| $53.6M | 0.03% |
518,765
-44,219
| -8% | -$4.57M |
|
379
ProAssurance
PRA
$1.22B
| $53.4M | 0.03% |
4,372,256
+205,295
| +5% | +$2.51M |
|
380
Quaker Houghton
KWR
$2.51B
| $52.9M | 0.03% |
311,746
-241,309
| -44% | -$41M |
|
381
Viavi Solutions
VIAV
$2.6B
| $52.7M | 0.03% |
7,669,683
+1,565,596
| +26% | +$10.8M |
|
382
Floor & Decor
FND
$9.42B
| $52.3M | 0.03% |
526,325
-98,626
| -16% | -$9.8M |
|
383
PRA Group
PRAA
$671M
| $52.2M | 0.03% |
2,657,194
+294
| +0% | +$5.78K |
|
384
RenaissanceRe
RNR
$11.3B
| $51.5M | 0.03% |
230,575
+21,354
| +10% | +$4.77M |
|
385
Old Dominion Freight Line
ODFL
$31.7B
| $51.2M | 0.03% |
289,793
+97,722
| +51% | +$17.3M |
|
386
HilleVax
HLVX
$105M
| $50.3M | 0.03% |
3,481,222
+419,518
| +14% | +$6.07M |
|
387
Neumora Therapeutics
NMRA
$272M
| $50.1M | 0.03% |
5,101,096
+1,517,092
| +42% | +$14.9M |
|
388
Doximity
DOCS
$13B
| $49.8M | 0.03% |
+1,779,805
| New | +$49.8M |
|
389
Black Diamond Therapeutics
BDTX
$167M
| $49.7M | 0.03% |
10,659,730
+3,934,365
| +59% | +$18.3M |
|
|
FBMS
390
DELISTED
The First Bancshares, Inc.
FBMS
| $49M | 0.03% |
1,887,796
-303,716
| -14% | -$7.89M |
|
391
Cathay General Bancorp
CATY
$3.43B
| $48.7M | 0.03% |
1,290,904
+73,462
| +6% | +$2.77M |
|
392
Equity Bancshares
EQBK
$811M
| $48.4M | 0.03% |
1,374,034
-31,640
| -2% | -$1.11M |
|
393
International Paper
IP
$25.7B
| $47.1M | 0.03% |
+1,091,546
| New | +$47.1M |
|
394
Warby Parker
WRBY
$3.17B
| $47.1M | 0.03% |
2,932,408
-1,125,577
| -28% | -$18.1M |
|
395
Immunome
IMNM
$916M
| $46.9M | 0.03% |
3,878,595
+2,362,141
| +156% | +$28.6M |
|
396
Certara
CERT
$1.69B
| $46.5M | 0.03% |
3,354,430
+152,132
| +5% | +$2.11M |
|
397
Matsons
MATX
$3.36B
| $46.4M | 0.03% |
354,490
+4,491
| +1% | +$588K |
|
398
Nurix Therapeutics
NRIX
$758M
| $45.7M | 0.03% |
+2,189,192
| New | +$45.7M |
|
399
Encore Capital Group
ECPG
$1.02B
| $45.4M | 0.03% |
1,087,679
-24,916
| -2% | -$1.04M |
|
400
Manhattan Associates
MANH
$13B
| $45.2M | 0.03% |
183,344
-188,099
| -51% | -$46.4M |
|